The arrival of a new financial sponsor cannot be overstated. Last season, the Shanghai Harbor's second team gained recognition for their impressive performances in the China League Two, sparking the ...

SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to discover and develop next-generation multi-specific antibodies for ...

Moreover, Harbor's display in the AFC Champions League has been disheartening. The team's path to the group stage was nearly derailed had it not been for Taishan team's withdrawal. In the subsequent ...

Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...

Pharma giant AstraZeneca announced on Friday that it is investing $2.5bn in a new global R&D centre in China, along with ...

LONDON (Reuters) - AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the ...

AstraZeneca (AZN) said Friday it plans to invest $2.5 billion in a new research and development hub in China as the drugmaker tries to reignite ...

This $2.5 billion investment reflects AstraZeneca's belief in "the world-class life sciences ecosystem in Beijing" and its ...

While AZ is eyeing overseas expansion with its new investment, J&J has embarked on a reshoring drive with a pledge to invest ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...